ClinicalTrials.Veeva

Menu
M

Medical University of Graz | Division of Gynecology and Obstetrics

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Vitamin D
Glucose
Lenalidomide
Vitamin D3
Pregabalin
Ritonavir
EMpagliflozin
Bevacizumab
Rivaroxaban
Atezolizumab

Parent organization

This site is a part of Medical University of Graz

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

15 of 215 total trials

A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome (POETYK SjS-1)

The purpose of this study is to assess the safety and efficacy of two doses of Deucravacitinib in adult participants with Active Sjögren's Syndrome.

Enrolling
Sjögren's Syndrome
Other: Placebo
Drug: Deucravacitinib

The study will investigate the safety of once weekly insulin icodec subcutaenously (s.c.) during and after exercise and prolonged fasting in patients...

Enrolling
Diabetes Mellitus, Type 2
Drug: Insulin degludec
Drug: Insulin icodec

The main objective is to determine whether a low-dose regimen of apixaban (2.5 mg bid) is non inferior to a full-dose regimen of apixaban (5 mg bid)...

Active, not recruiting
Cancer-associated Thrombosis
Drug: Apixaban 5 MG

This is a phase III, randomized, double-blinded, comparative, multi-centre study to assess the efficacy of atezolizumab in combination with platinum-...

Active, not recruiting
Ovarian Cancer
Drug: placebo + avastin + platinum-based chemotherapy
Drug: atezolizumab + avastin + platinum-based chemotherapy

The RESTORE (ATK) above the knee study is a prospective, non- randomized, multi-center study for treatment of stenotic lesions with the Bolt Intravas...

Active, not recruiting
Peripheral Vascular Diseases
Peripheral Arterial Disease
Device: Intravascular Lithotripsy

This study is researching an experimental drug called REGN3767, also known as fianlimab (R3767), when combined with another medication called REGN281...

Enrolling
Melanoma
Drug: Cemiplimab
Drug: Placebo

The purpose of this study is to evaluate the safety and efficacy of Hyalofast® scaffold with bone marrow aspirate concentrate (BMAC) compared to micr...

Active, not recruiting
Defect of Articular Cartilage
Device: Hyalofast
Procedure: Microfracture

The primary objective of this study (LANDMARK) is to compare the safety and effectiveness of the Myval THV Series with Contemporary Valves (Sapien TH...

Enrolling
Aortic Valve Stenosis
Device: Contemporary Valves (Sapien THV Series and Evolut THV Series)
Device: Myval THV Series

A multicenter, open-label Phase 2b study of selinexor (KPT-330) in participants with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL)...

Enrolling
Diffuse Large B-cell Lymphoma
Drug: Selinexor

Many patients with Crohn's disease develop fibrotic narrowing (strictures) in their bowel, causing obstructive symptoms such as abdominal pain, cramp...

Enrolling
Fibrostenotic Crohn's Disease
Drug: AGMB-129
Drug: Placebo

This study evaluates intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell car...

Active, not recruiting
Squamous Cell Carcinoma of the Skin
Melanoma (Skin)
Biological: CV8102
Biological: CV8102 + anti-PD-1 therapy

The Study will evaluate the effects of VVX001, a novel vaccine for hepatitis B, to* elicit a robust protective IgG immune response in vaccine naive s...

Enrolling
Hepatitis B
Biological: Placebo
Biological: VVX001

This study compares the efficacy of Tamibarotene in combination with azacitidine to azacitidine in combination with placebo in participants who are R...

Enrolling
Myelodysplastic Syndromes
Drug: Azacitidine
Drug: Tamibarotene

The Chocolate Touch study is a randomized, multi-center, prospective, adaptive study, designed to show sufficient safety and effectiveness of the Cho...

Active, not recruiting
Peripheral Artery Disease (PAD)
Intermittent Claudication
Device: Chocolate Touch
Device: Lutonix Drug Coated Balloon

The trial objective is to investigate whether Fractional Flow Reserve (FFR)-Guided Percutaneous Coronary Intervention (PCI) and TransCatheter Aortic...

Active, not recruiting
Multi Vessel Coronary Artery Disease
Fractional Flow Reserve
Device: FFR-guided PCI and TAVI
Device: CABG and SAVR

Trial sponsors

M
Medical University of Vienna logo
U
C
Celgene logo
E
U
B
C
P

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems